New molecular evidence from the University of Colorado Anschutz College shows how common permanent chemicals interfere with early developmental pathways in fetuses.
A newly published study identifies the precise biological mechanism by which widely detected PFAS compounds may interfere with facial development during pregnancy, providing one of the clearest explanations yet of how these persistent environmental chemicals affect fetal development.
The study, published in ACS Chemical Research in Toxicology, focuses on perfluorodecanoic acid (PFDA). Perfluorodecanoic acid (PFDA) is a member of the perfluoroalkyl and polyfluoroalkyl substances (PFAS) group.
These chemicals are sometimes called eternal chemicals because they are not easily broken down by the environment or the human body.
Evidence goes beyond correlation
Although years of epidemiological studies have linked PFAS exposure to developmental abnormalities, the underlying biological processes remain poorly understood.
This latest study moves the discussion from correlation to causation by identifying how PFDA interferes with important developmental pathways.
Researchers screened 139 PFAS compounds commonly found in industrial and consumer applications. Among them, PFDA was found to have a particularly devastating effect on facial development in early stage embryos.
Even at very low exposure levels, this compound produced measurable effects, and the risk increased stepwise as exposure increased.
This finding suggests that not all PFAS compounds pose the same risks, and this distinction may prove important in regulatory prioritization and chemical design.
Destruction of retinoic acid in the nucleus
At the heart of this discovery is retinoic acid, a vitamin A-derived molecule that plays a central role in fetal development. It regulates gene expression during early embryogenesis, especially head and face formation.
Precise control of retinoic acid levels is essential. Excess or deficiency can both cause developmental abnormalities.
The developing fetus is unable to regulate or eliminate excess retinoic acid on its own, so it depends entirely on the mother’s physiological processes to maintain the balance.
This study found that PFDA disrupts this balance in two different ways.
Enzyme inhibition and gene silencing
First, PFDA inhibits the enzyme CYP26A1, which breaks down excess retinoic acid. When this enzyme is inhibited, retinoic acid accumulates above safe levels.
Second, this compound suppresses the gene encoding CYP26A1 through another biological pathway. This dual interference creates a compounding effect that severely impairs the body’s ability to regulate retinoic acid during critical stages of fetal development.
As a result, the tightly controlled signaling required for normal facial development is disrupted.
Observable effects on fetal development
Biological disruptions identified in the study are translated into visible structural abnormalities. The most commonly observed outcomes included ocular hypoplasia and jaw malformations.
Although these types of craniofacial abnormalities are consistent with previous observational studies, the new findings provide a previously missing mechanistic explanation.
Importantly, this study shows that even minimal exposure may be sufficient to cause these effects, raising questions about current safety thresholds.
Risk assessment and regulatory implications
This research has broader implications for how PFAS are evaluated and regulated. With an estimated 15,000 PFAS compounds in use, comprehensive testing for each is currently not possible.
This study opens the door to more efficient screening methods by identifying specific molecular pathways associated with toxicity.
Developing laboratory assays and computational models to identify compounds that interfere with the regulation of retinoic acid could allow regulators to prioritize substances with higher risks.
Such tools may also support the development of safer chemical alternatives by highlighting structural features associated with toxicity.
Exposure risks and future research
Although most people encounter low levels of PFAS through everyday sources, exposure to high concentrations of PFAS can occur in certain situations, such as contaminated water supplies, industrial settings, and occupations such as firefighting and ski waxing.
Researchers suggest that understanding the mechanisms of harm could inform targeted interventions. These may include strategies to reduce exposure to PFDA and approaches to reduce its effects during pregnancy.
Further research will be needed to determine whether similar mechanisms apply to other PFAS compounds and assess potential clinical or public health responses.
Source link
